Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ludovicus Staelens is active.

Publication


Featured researches published by Ludovicus Staelens.


Arthritis & Rheumatism | 2006

Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

Ken Coppieters; Torsten Dreier; Karen Silence; Hans De Haard; Marc Lauwereys; Peter Casteels; Els Beirnaert; Heidi Maria Florence Jonckheere; Christophe Van de Wiele; Ludovicus Staelens; Jeroen Hostens; Hilde Adi Pierette Revets; Erik Remaut; Dirk Elewaut; Pieter Rottiers


Nuclear Medicine and Biology | 2005

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker

Bart Cornelissen; Ruth Oltenfreiter; Veerle Kersemans; Ludovicus Staelens; Francis Frankenne; Jean-Michel Foidart; Guido Slegers


Nuclear Medicine and Biology | 2004

New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents

Ruth Oltenfreiter; Ludovicus Staelens; Annabelle Lejeune; Filip Dumont; Francis Frankenne; Jean-Michel Foidart; Guido Slegers


Cancer Biotherapy and Radiopharmaceuticals | 2005

Tryptophane-Based Biphenylsulfonamide Matrix Metalloproteinase Inhibitors as Tumor Imaging Agents

Ruth Oltenfreiter; Ludovicus Staelens; Soraya Labied; Veerle Kersemans; Francis Frankenne; Agnès Noël; Christophe Van de Wiele; Guido Slegers


British Journal of Radiology | 2005

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice

Bart Cornelissen; Veerle Kersemans; Lennart Jans; Ludovicus Staelens; Ruth Oltenfreiter; Thomas Thonissen; Eric Achten; Guido Slegers


Applied Radiation and Isotopes | 2005

Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents ☆

Ruth Oltenfreiter; Ludovicus Staelens; Ulrik Hillaert; An Heremans; Agnès Noël; Francis Frankenne; Guido Slegers


Applied Radiation and Isotopes | 2006

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents

Ruth Oltenfreiter; Ludovicus Staelens; Veerle Kersemans; Bart Cornelissen; Francis Frankenne; Jean-Michel Foidart; Christophe Van de Wiele; Guido Slegers


Arthritis & Rheumatism | 2005

Formatted anti-TNF-alpha nanobodies show superior efficacy in a collagen-induced arthritis model in mice

Ken Coppieters; Torsten Dreier; Karen Silence; H De Gaard; Marc Lauwereys; C Peter; Christophe Van de Wiele; Ludovicus Staelens; Jeroen Hostens; Hilde Adi Pierette Revets; Erik Remaut; Dirk Elewaut; Pieter Rottiers


Nuclear Medicine and Biology | 2005

In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies

Ludovicus Staelens; Ruth Oltenfreiter; Filip Dumont; Rikki N. Waterhouse; Katia Vandenbulcke; Peter Blanckaert; Rudi Dierckx; Guido Slegers


European Journal of Nuclear Medicine and Molecular Imaging | 2008

(123)I-interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma

David Loose; Alberto Signore; Ludovicus Staelens; Katia Vanden Bulcke; Hubert Vermeersch; Rudi Dierckx; Elena Bonanno; Christophe Van de Wiele

Collaboration


Dive into the Ludovicus Staelens's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rudi Dierckx

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge